hand-wrist pathology
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? A new patients who will undergo a radiography of their wrist and/or hand; ? Referral to the radiology department of the RdGG for radiography; ? Age 18 years or over; ? Signed informed consent (see E2 submission request); ? Main problem concerns wrist and/or hand complaints.
Exclusion criteria
Exclusion criteria: ? Not mastering the Dutch or English language; ? Patients who have undergone imaging of their wrist and/or hand over the past 12 months because of ipsilateral complaints; ? Incapable of understanding the ramifications of participation; ? Wrist or hand infection (osteomyelitis); ? Pre-existent neurological pathology in the affected limb;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study endpoint is the incidence of wrist and/or hand pathologies on radiography in adult patients (= 18 year). Traumatic and non-traumatic diagnosed abnormalities on radiography at baseline are: ? wrist or hand fracture characteristics (fracture type, location); ? wrist or hand osteoarthritis characteristics (osteoarthritis score, location); ? no abnormalities (no fracture or osteoarthritis) were diagnosed by radiography examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient reported outcomes will be measured at baseline and 6 weeks, 3 months and 12 months after baseline. Outcomes will be measured with the Patient-Rated Wrist Hand Evaluation (PRWHE-score: see F1 submission request), Australian/Canadian Hand Osteoarthritis Index (AUSCAN: see F1 submission request), Numeric Pain Rating Scale-score (NPRS: see F1 submission request), Pain Catastrophizing Scale (PCS: see F1 submission request), Hospital Anxiety and Depression Scale (HADS: see F1 submission request), Patients Perceived Recovery and Outcome (see page 17) and the modified version of the Functional Comorbidity Index (FCI: see F1 submission request) ? Severity of symptoms (pain) of wrist or hand (PRWHE, AUSCAN and NPRS) at all time points (baseline, 6 weeks, 3 months and 12 months); ? Functional impairment of wrist or hand (PRWHE and AUSCAN) at all time points (baseline, 6 weeks, 3 months and 12 months); ? PCS and HADS will be completed at all time points (baseline, 6 weeks, 3 months and 12 months) to determine psychological factors related with the outcome; ? The modified version of the FCI will be completed at baseline to determine comorbidity; ? Patients-Perceived Recovery and Outcome will be measured at 6 weeks, 3 months and 12 months to determine perception of recovery. In addition to the questionnaires, we will score additional outcomes. ? Rare abnormalities: anatomical variants, congenital deformations, abutments syndromes, rheumatoid arthritis, hemochromatosis, gout tophi, psoriatic arthritis, bone deformities (osteomalacia, Swann neck deformity, Boutonniere deformity); ? Neoplasia, benign tumors (chondrosarcoma, osteosarcoma, enchondroma, metastatic cancer) and malignant tumors; | — |
Contacts
Reinier Haga Orthopedisch Centrum